| # | % | |||||
|---|---|---|---|---|---|---|
| 1 | ATRICURE INC | 487,946 | 10,950,000 | 9.76% | SH | |
| 2 | NXSTAGE MED INC COM | 366,554 | 8,031,000 | 7.16% | SH | |
| 3 | ABBVIE INC | 116,581 | 6,906,000 | 6.16% | ||
| 4 | MARINUS PHARMACEUTICALS INC | 566,498 | 4,328,000 | 3.86% | ||
| 5 | INSULET CORPORATION | 106,018 | 4,009,000 | 3.57% | SH | |
| 6 | CTI BIOPHARMA CORP | 3,195,381 | 3,930,000 | 3.50% | SH | |
| 7 | AERIE PHARMACEUTICALS INC | 148,369 | 3,613,000 | 3.22% | SH | |
| 8 | VITAE PHARMACEUTICALS INC | 193,224 | 3,497,000 | 3.12% | ||
| 9 | RIGEL PHARMACEUTICAL INC | 1,109,740 | 3,363,000 | 3.00% | SH | |
| 10 | APPLIED GENETIC TECHNOL CORP | 157,192 | 3,207,000 | 2.86% | ||
| 11 | CARA THERAPEUTICS INC | 169,331 | 2,855,000 | 2.55% | ||
| 12 | BIOTELEMETRY INC COM | 235,645 | 2,752,000 | 2.45% | SH | |
| 13 | BIOCRYST PHARMACEUTICALS | 255,642 | 2,638,000 | 2.35% | SH | |
| 14 | ACHILLION PHARMACEUTICALS INC COM | 236,500 | 2,552,000 | 2.27% | SH | |
| 15 | INSULET CORP 2 06/15/2019 | 2,407,000 | 2,512,000 | 2.24% | PRN | |
| 16 | MASIMO CORP COM | 46,010 | 1,910,000 | 1.70% | SH | |
| 17 | GALAPAGOS NV | 30,000 | 1,886,000 | 1.68% | ||
| 18 | PROTALIX BIOTHERAPEUTICS INC | 2,500,000 | 1,775,000 | 1.58% | PRN | |
| 19 | LOXO ONCOLOGY INC COM | 61,737 | 1,756,000 | 1.57% | ||
| 20 | SYNERGY PHARMACEUTICALS DEL COM NEW | 294,563 | 1,670,000 | 1.49% | ||
| 21 | CELYAD SA | 30,000 | 1,638,000 | 1.46% | ||
| 22 | DERMA SCIENCES INC COM PAR .01 | 353,718 | 1,616,000 | 1.44% | SH | |
| 23 | TOBIRA THERAPEUTICS INC | 160,353 | 1,612,000 | 1.44% | ||
| 24 | DISCOVERY LABORATORIES INC N | 7,467,032 | 1,597,000 | 1.42% | SH | |
| 25 | CYTRX CORP | 583,013 | 1,545,000 | 1.38% | SH | |
| 26 | Dicerna Pharmaceuticals | 120,600 | 1,432,000 | 1.28% | ||
| 27 | AVALANCHE BIOTECHNOLOGIES IN | 140,600 | 1,339,000 | 1.19% | ||
| 28 | NOVADAQ TECHNOLOGIES INC | 101,841 | 1,297,000 | 1.16% | SH | |
| 29 | SPECTRANETICS CORP | 79,812 | 1,202,000 | 1.07% | SH | |
| 30 | NUVASIVE INC | 760,000 | 1,045,000 | 0.93% | PRN | |
| 31 | ESSA Pharma | 228,500 | 1,045,000 | 0.93% | ||
| 32 | ZOGENIX INC | 69,400 | 1,023,000 | 0.91% | ||
| 33 | Stereotaxis Inc | 1,372,862 | 1,021,000 | 0.91% | SH | |
| 34 | Ascendis Pharma | 53,241 | 975,000 | 0.87% | ||
| 35 | SCYNEXIS INC | 156,904 | 974,000 | 0.87% | SH | |
| 36 | JOHNSON & JOHNSON | 9,400 | 966,000 | 0.86% | SH | |
| 37 | NEOS THERAPEUTICS INC COM | 63,400 | 908,000 | 0.81% | ||
| 38 | CAREDX INC | 136,047 | 871,000 | 0.78% | SH | |
| 39 | XENON PHARMACEUTICALS INC | 97,730 | 786,000 | 0.70% | ||
| 40 | REGULUS THERAPEUTICS INC | 90,000 | 785,000 | 0.70% | ||
| 41 | MACROGENICS INC | 24,000 | 743,000 | 0.66% | ||
| 42 | ARENA PHARMACEUTICALS INC | 381,600 | 725,000 | 0.65% | ||
| 43 | CYNAPSUS THERAPEUTICS INC | 46,629 | 722,000 | 0.64% | ||
| 44 | SYNERON MEDICAL LTD ORD SHS | 85,947 | 663,000 | 0.59% | SH | |
| 45 | LIPOCINE INC NEW | 50,000 | 647,000 | 0.58% | ||
| 46 | Intec Pharma Ltd | 119,296 | 639,000 | 0.57% | ||
| 47 | ABEONA THERAPEUTICS INC | 181,818 | 611,000 | 0.54% | ||
| 48 | ALDER BIOPHARMACEUTICALS INC | 18,000 | 595,000 | 0.53% | ||
| 49 | ADAPTIMMUNE THERAPEUTICS PLC | 48,100 | 580,000 | 0.52% | ||
| 50 | UNIQURE NV | 35,000 | 579,000 | 0.52% | SH |
Portfolio data is normalized using SEC Form 13F filings, including the Original 13F-HR (0001389933-16-000022, filed 2016.02.12).
From 2023-01-03 onward, the SEC requires values to be reported in nearest dollars. Earlier filings reported values in thousands; therefore, positions shown as $0 in older filings may represent actual values between $0–$999.
